Form 8-K - Current report:
SEC Accession No. 0001493152-25-002144
Filing Date
2025-01-14
Accepted
2025-01-14 16:15:24
Documents
15
Period of Report
2025-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45632
2 ex10-1.htm EX-10.1 13445
  Complete submission text file 0001493152-25-002144.txt   287424

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE biaf-20250110.xsd EX-101.SCH 3787
4 XBRL DEFINITION FILE biaf-20250110_def.xml EX-101.DEF 30036
5 XBRL LABEL FILE biaf-20250110_lab.xml EX-101.LAB 36679
6 XBRL PRESENTATION FILE biaf-20250110_pre.xml EX-101.PRE 27059
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5821
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25529543
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)